GCG and fatty liver disease: Although inconsistent data is available [84,85], most studies subsequently confirmed the in vivo benefit of GLP-1 RAs on fatty liver disease [50,56,57,58,61,71,74,76,77,81,84,85,86,87,88,89,90] (Table 3).